Leo James co-founds new UK biotech company together with Will McEwan (UK DRI at Cambridge) leveraging the unique properties of TRIM21, discovered at the LMB.
LMB spinout TRIMTECH Therapeutics will develop targeted protein degraders to treat neurodegenerative conditions
Sortera Bio spins out of the LMB to pioneer new frontiers in biologics discovery
New UK-based biotechnology company launched to realise therapeutic potential of Deep Screening technology developed by Ben Porebski and Philipp Holliger at the LMB.
Shankar Balasubramanian to deliver 2025 Francis Crick Lecture
The 2025 Francis Crick Lecture titled ‘The DNA Quadruplex Helix’ will be given by Shankar Balasubramanian at 11am on Wednesday 19th February.
Festive fundraising totals over £1400 for Pets As Therapy
The annual LMB Christmas charity raffle and Craft and Chatter group Christmas sale has raised over £1400 for Pets As Therapy.
John Sutherland awarded Stanley Miller Medal from National Academy of Sciences
John Sutherland, Group Leader in the LMB’s PNAC Division, has received the Award in Early Earth and Life Sciences – Stanley Miller Medal from the National Academy of Sciences.
The LMB welcomes new Group Leader Roni Levin Konigsberg
Roni Levin Konigsberg joins the LMB’s Cell Biology Division, where he will lead a group investigating the molecular physiology of phagocytic cells.